When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NBRV - EMA accepts Nabriva's application for antibiotic lefamulin; shares up 6% after hours
Nabriva Therapeutics plc
Nabriva Therapeutics (NASDAQ:NBRV) is up 6% after hours in reaction to its announcement that the European Medicines Agency (EMA) has accepted for review its marketing application for intravenous and oral formulations of lefamulin for the treatment of community-acquired pneumonia in adult patients.
More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stocks on the move,